Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton

SETD2 is known to be the unique histone methyltransferase responsible for the trimethylation of the lysine 36 of histone H3 thus generating H3K36me3. This epigenetic mark is critical for transcriptional activation and elongation, DNA repair, mRNA splicing, and DNA methylation. Recurrent SETD2-inacti...

Full description

Saved in:
Bibliographic Details
Main Authors: Christina Michail, Fernando Rodrigues Lima, Mireille Viguier, Frédérique Deshayes
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558624001313
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850251144060731392
author Christina Michail
Fernando Rodrigues Lima
Mireille Viguier
Frédérique Deshayes
author_facet Christina Michail
Fernando Rodrigues Lima
Mireille Viguier
Frédérique Deshayes
author_sort Christina Michail
collection DOAJ
description SETD2 is known to be the unique histone methyltransferase responsible for the trimethylation of the lysine 36 of histone H3 thus generating H3K36me3. This epigenetic mark is critical for transcriptional activation and elongation, DNA repair, mRNA splicing, and DNA methylation. Recurrent SETD2-inactivating mutations and altered H3K36me3 levels are found in cancer at high frequency and numerous studies indicate that SETD2 acts as a tumor suppressor. Recently, SETD2 was further shown to methylate non-histone proteins particularly the cytoskeletal proteins tubulin and actin with subsequent impacts on cytoskeleton structure, mitosis and cell migration.Herein, we provide a review of the role of SETD2 in different cancers with special emphasis on the structural basis of the functions of this key lysine methyltransferase. Moreover, beyond the role of this enzyme in epigenetics and H3K36me3-dependent processes, we highlight the putative role of ''non-epigenetic/H3K36me3'' functions of SETD2 in cancer, particularly those involving the cytoskeleton.
format Article
id doaj-art-e28ad0a71a05407dad5e3418594feccd
institution OA Journals
issn 1476-5586
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Neoplasia: An International Journal for Oncology Research
spelling doaj-art-e28ad0a71a05407dad5e3418594feccd2025-08-20T01:57:59ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55862025-01-015910109010.1016/j.neo.2024.101090Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeletonChristina Michail0Fernando Rodrigues Lima1Mireille Viguier2Frédérique Deshayes3Université Paris Cité, CNRS, Unité de Biologie Fonctionnelle et Adaptative, F-75013 Paris, FranceUniversité Paris Cité, CNRS, Unité de Biologie Fonctionnelle et Adaptative, F-75013 Paris, FranceCorresponding authors.; Université Paris Cité, CNRS, Unité de Biologie Fonctionnelle et Adaptative, F-75013 Paris, FranceCorresponding authors.; Université Paris Cité, CNRS, Unité de Biologie Fonctionnelle et Adaptative, F-75013 Paris, FranceSETD2 is known to be the unique histone methyltransferase responsible for the trimethylation of the lysine 36 of histone H3 thus generating H3K36me3. This epigenetic mark is critical for transcriptional activation and elongation, DNA repair, mRNA splicing, and DNA methylation. Recurrent SETD2-inactivating mutations and altered H3K36me3 levels are found in cancer at high frequency and numerous studies indicate that SETD2 acts as a tumor suppressor. Recently, SETD2 was further shown to methylate non-histone proteins particularly the cytoskeletal proteins tubulin and actin with subsequent impacts on cytoskeleton structure, mitosis and cell migration.Herein, we provide a review of the role of SETD2 in different cancers with special emphasis on the structural basis of the functions of this key lysine methyltransferase. Moreover, beyond the role of this enzyme in epigenetics and H3K36me3-dependent processes, we highlight the putative role of ''non-epigenetic/H3K36me3'' functions of SETD2 in cancer, particularly those involving the cytoskeleton.http://www.sciencedirect.com/science/article/pii/S1476558624001313CancerCytoskeletonGenetic alterationsHistonesSETD2Structure
spellingShingle Christina Michail
Fernando Rodrigues Lima
Mireille Viguier
Frédérique Deshayes
Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton
Neoplasia: An International Journal for Oncology Research
Cancer
Cytoskeleton
Genetic alterations
Histones
SETD2
Structure
title Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton
title_full Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton
title_fullStr Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton
title_full_unstemmed Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton
title_short Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton
title_sort structure and function of the lysine methyltransferase setd2 in cancer from histones to cytoskeleton
topic Cancer
Cytoskeleton
Genetic alterations
Histones
SETD2
Structure
url http://www.sciencedirect.com/science/article/pii/S1476558624001313
work_keys_str_mv AT christinamichail structureandfunctionofthelysinemethyltransferasesetd2incancerfromhistonestocytoskeleton
AT fernandorodrigueslima structureandfunctionofthelysinemethyltransferasesetd2incancerfromhistonestocytoskeleton
AT mireilleviguier structureandfunctionofthelysinemethyltransferasesetd2incancerfromhistonestocytoskeleton
AT frederiquedeshayes structureandfunctionofthelysinemethyltransferasesetd2incancerfromhistonestocytoskeleton